VentriLabs

VentriLabs is partnering with Semcon and Chalmers University of Technology to offer a master thesis project focused on computational fluid dynamics (#CFD). Are you passionate about innovation and product development? This is your chance to contribute to cutting-edge research and make a real impact. For more details, feel free to reach out to Bastian or Robin! #MasterThesis #Innovation #ComputationalFluidDynamics #VentriLabs #Semcon

Cardiovascular disease (#CVD) remains the leading cause of death worldwide, as highlighted by the World Health Organization (WHO). According to the American Heart Association every 40 seconds, someone in the U.S. will have a heart attack. This places immense pressure on healthcare systems, making advanced technologies and innovative treatment methods more important than ever to improve patient outcomes while minimizing risks. At VentriLabs, we are proud to be contributing to the development of tomorrow's life-saving medical equipment. Our innovative pump technology is developed with the patient in mind, aiming to enhance the safety and effectiveness of circulatory support systems to ultimately improve the treatment of patients in need of external circulatory support. #HealthcareInnovation #MedTech #CVD #ECMO #CPB

The VentriLabs team is growing! 🌟 We’re thrilled to welcome Ulf Andersson to our Board of Directors. With over a decade of experience in medical technologies, including leadership roles at Getinge, Ulf brings invaluable expertise in product development and innovation. His strategic insights will drive forward our mission to advance cutting-edge medical technologies. Welcome aboard, Ulf! #MedTech #Leadership #Innovation #VentriLabs

Wrapping up an incredible three weeks at the Testa Challenge! The past weeks have been an inspiring and eye-opening journey, filled with insights and fresh ideas on how VentriLabs' innovative pump technology can bring even more value to the bioprocessing industry. A heartfelt thank you to Testa Center and Cytiva for hosting such a fantastic initiative and for the opportunity to be part of this year’s Testa Challenge. Also, a huge shoutout to all the amazing companies from across Europe who joined us—we're grateful for the great conversations and shared experiences! Excited to see where these new ideas take us! Exner Process Equipment GmbH, QUBICON, Timegate Instruments Ltd., InSpek, Envue Technologies

🌟 This summer, VentriLabs had the incredible opportunity to participate in a collaborative project with Sahlgrenska Science Park, CO-AX Incubator & Accelerator, and the University of California, Berkeley, Haas School of Business and UC-Berkeley Deep Tech Innovation Lab. 🌍 As part of their education, a talented group of students from diverse backgrounds joined forces to map the IP and market landscapes for VentriLabs. Their fresh perspectives and in-depth analysis have provided us with valuable insights that will help shape our future. A huge thank you to Bowman, Matt, and Annica for making this opportunity possible. Your support has been instrumental in driving VentriLabs forward! 🚀

Proud to be part of Biotech Fluidics, a market leading company within fluidic systems and components! Exciting times ahead!

We’re thrilled to share that VentriLabs has been selected to participate in the prestigious Testa Challenge 2024! This incredible opportunity allows us to test and evaluate our cutting-edge gravity-mediated #pump technology in a real-world #bioprocessing environment. A total of six European companies were granted this honor. We’re excited to join forces with the talented teams from QUBICON, Exner Process Equipment GmbH, Envue Technologies, InSpek, and Timegate Instruments Ltd. at this renowned annual event, organized by Testa Center, part of Cytiva. We can't wait to collaborate and innovate together! Read more: https://lnkd.in/d9W4FqFy #TestaChallenge2024 #biopharma #bioprocessing #innovation #LifeScience

Sahlgrenska Science Park and CO-AX Incubator & Accelerator announce the launch of VentriLabs in a new press release. Find out more below! #Innovation #MedTech #LifeScience #Biotech

We’re excited to introduce VentriLabs, a pioneering MedTech and Biotech company on a mission to revolutionize liquid pumping technology. After years of rigorous research and development, we are thrilled to officially go public. Our proprietary, gravity-mediated liquid pump technology is designed to handle delicate liquids with unmatched safety and precision. VentriLabs is poised to make a significant impact in Life Science sectors, including bioprocessing, tissue engineering, and clinical perfusion. We’re eager to explore new collaborations, partnerships, and investment opportunities. Make sure to follow our LinkedIn page for updates on our journey and all exciting news to come! Join us on this exciting journey!